Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADYX Adynxx	$0.00	$0.00 ▼ $0.00	N/A	2.67	833 shs	N/A
AKSY Aksys	$0.00	$0.00 ▼ $0.00	N/A	N/A	N/A	N/A
NXNN Nexeon Medsystems	$0.00	$0.00 ▼ $0.00	N/A	6.98	300 shs	200 shs
WWIN AllyMe Group	$0.00	$7.25 ▼ $70.00	N/A	N/A	133 shs	100 shs

These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADYX Adynxx	0.00%	0.00%	0.00%	0.00%	0.00%
AKSY Aksys	0.00%	0.00%	0.00%	0.00%	0.00%
NXNN Nexeon Medsystems	0.00%	0.00%	0.00%	0.00%	0.00%
WWIN AllyMe Group	0.00%	0.00%	0.00%	0.00%	0.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ADYX Adynxx	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
AKSY Aksys	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NXNN Nexeon Medsystems	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
WWIN AllyMe Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating	Consensus Price Target	% Upside from Current Price
ADYX Adynxx	N/A	N/A	N/A
AKSY Aksys	N/A	N/A	N/A
NXNN Nexeon Medsystems	N/A	N/A	N/A
WWIN AllyMe Group	N/A	N/A	N/A

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ADYX Adynxx	N/A	N/A	N/A	N/A	N/A	N/A
AKSY Aksys	N/A	N/A	N/A	N/A	N/A	N/A
NXNN Nexeon Medsystems	N/A	N/A	N/A	N/A	N/A	N/A
WWIN AllyMe Group	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ADYX Adynxx	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
AKSY Aksys	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NXNN Nexeon Medsystems	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
WWIN AllyMe Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ADYX Adynxx	N/A	N/A	N/A	N/A	N/A
AKSY Aksys	N/A	N/A	N/A	N/A	N/A
NXNN Nexeon Medsystems	N/A	N/A	N/A	N/A	N/A
WWIN AllyMe Group	N/A	N/A	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ADYX Adynxx	N/A
AKSY Aksys	N/A
NXNN Nexeon Medsystems	N/A
WWIN AllyMe Group	N/A

Insider Ownership

Company	Insider Ownership
ADYX Adynxx	17.40%
AKSY Aksys	3.80%
NXNN Nexeon Medsystems	61.19%
WWIN AllyMe Group	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ADYX Adynxx	6	830,000	N/A	Not Optionable
AKSY Aksys	87	N/A	N/A	Not Optionable
NXNN Nexeon Medsystems	60	N/A	N/A	Not Optionable
WWIN AllyMe Group	N/A	N/A	N/A	Not Optionable

NXNN, ADYX, AKSY, and WWIN Headlines

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

NXNN, ADYX, AKSY, and WWIN Company Descriptions

Adynxx OTCMKTS:ADYX

Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.

Aksys OTCMKTS:AKSY

Aksys Ltd. provides hemodialysis products and services for patients suffering from end-stage renal disease, known as chronic kidney failure. The company offers an automated personal hemodialysis system, known as the Aksys PHD, a Personal Hemodialysis System (PHD System), which is designed to enable patients to perform frequent hemodialysis at alternate sites, such as their own homes. The PHD System is designed to monitor, during the treatment, various vital statistics, including the patient's blood flow rate, the amount of water removed from the patient, the length of the treatment session, and other parameters. It also evaluates the performance of the artificial kidney in removing toxins from the patient's blood prior to each treatment, as well as automatically evaluates the water treatment filters and indicates whether a replacement is required and verifies that safety systems, sensors, and alarms are operating correctly. Aksys Ltd. also provides various services, including the delivery and installation of the PHD System; technical services, including maintenance and repair of the PHD System; delivery of consumables used in dialysis, such as the water purification components and dialysate concentrate; and artificial kidney, and arterial and venous blood tubing. The company markets its products and services, primarily to healthcare providers, such as hospitals, dialysis clinics, managed care organizations, and nephrology physician groups in the United States, the United Kingdom, and Japan. Aksys Ltd. was founded in 1991 and is headquartered in Lincolnshire, Illinois.

Nexeon Medsystems OTCMKTS:NXNN

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.

AllyMe Group OTCMKTS:WWIN

Allyme Group, Inc. engages in providing consulting services in China principally focused on the development of new-high-tech products marketing and retail sales. It seeks to provide management advisory services to business organizations worldwide. The company intends to assist smaller developing companies in the development of business models and strategies. It offers business, marketing, financial consultancy and business modelling support to its client organizations. The company was founded on August 13, 2014 and is headquartered in Los Angeles, CA.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time